An Open-Label Feasibility and Safety Study of MDMA-Assisted Group Therapy for the Treatment of Posttraumatic Stress Disorder in Veterans Receives Full IRB Approval

In January 2022, our Phase 2 study to assess MDMA-assisted group therapy for the treatment of PTSD in veterans received full approval by the Institutional Review Board (IRB). The study is located at the Portland Veterans Affairs (VA) Medical Center in Oregon and led by Principal Investigator Chris Stauffer, M.D. This is an open-label, non-randomized, three cohort study and will include up to 18 participants.